In the context of sepsis immune monitoring, several basal-state biomarkers (i.e. without prior stimulation) are routinely used in clinical practice, such as mHLA-DR, CD4+/CD8+ ratio, and circulating IL-10 [27]. This evidence concerns the gene CD4 and Sepsis.